Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial--VIP report no. 1
2001
Abstract
To determine if photodynamic therapy with verteporfin (Visudyne; CIBA Vision Corp, Duluth, GA) can improve the chance of stabilizing or improving vision (<8 letter loss) safely in patients with subfoveal choroidal neovascularization (CNV) caused by pathologic myopia.
Details
Title
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial--VIP report no. 1
Author(s)
VipStudy, Group
Published in
Ophthalmology
Volume
108
Issue
5
Pages
841-52
Date
2001
Publisher
Elsevier
ISSN
0161-6420
Keywords
Record Appears in
Scientific production and competences > ENAC - School of Architecture, Civil and Environmental Engineering > ENAC Archives > LPAS - Air and Soil Pollution Laboratory
Scientific production and competences > STI - School of Engineering > STI Archives > GR-VDB - Van den Bergh Group
Scientific production and competences > SB - School of Basic Sciences > SB Archives > GR-VDB - Van den Bergh Group
Peer-reviewed publications
Work produced at EPFL
Journal Articles
Published
Scientific production and competences > STI - School of Engineering > STI Archives > GR-VDB - Van den Bergh Group
Scientific production and competences > SB - School of Basic Sciences > SB Archives > GR-VDB - Van den Bergh Group
Peer-reviewed publications
Work produced at EPFL
Journal Articles
Published
Record creation date
2011-02-16